Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Oral Health Reports
Published in: Current Oral Health Reports 1/2019

01-03-2019 | Gingival Diseases | Systemic Diseases (N Buduneli, Section Editor)

Biomarkers in Saliva and Serum Samples for Periodontal Disease and Interactions with Systemic Health

Author: Nurcan Buduneli

Published in: Current Oral Health Reports | Issue 1/2019

Login to get access

Abstract

Purpose of Review

This review examines the current literature on the potential of systemic biomarkers for diagnosing and monitoring periodontal diseases and also their role in the interaction with systemic diseases.

Recent Findings

Numerous potential biomarkers in saliva or serum samples have been investigated in mainly cross-sectional, but also in some longitudinal studies. Periodontal diseases are multifactorial in nature and clinical findings are the result of the interactions between microorganisms and host response. Moreover, systemic health, genetic factors, psychological stress, and environmental factors can have significant impact on the clinical outcomes. Therefore, it is not realistic to find a single biomarker for diagnosis and monitoring of periodontal diseases. However, there are enzymes and inflammatory cytokines that may discriminate healthy periodontium from gingivitis/periodontitis and some others may partly explain the mechanisms of interaction between periodontal disease and systemic diseases.

Summary

Recent publications have revealed some significant associations between various potential biomarkers and clinical periodontal parameters, but larger scale and intervention studies are required to better clarify the issue.
Literature
1.
• Kinane DF, Chestnutt IG. Relationship of diabetes to periodontitis. Curr Opin Periodontol. 1997;4:29–34 This paper emphasises the special interaction between diabetes and periodontitis showing the path for further research. PubMed
2.
Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner ACR, Yu WH, et al. The human oral microbiom. J Bacteriol. 2010;192:5002–17.CrossRef
3.
Larsen T, Fiehn N-E. Dental biofilm infections–an update. APMIS. 2017;125:376–84.CrossRef
4.
• Loos BG, Papantonopoulos G, Jepsen S, Laine ML. What is the contribution of genetics to periodontal risk? Dent Clin N Am. 2015;59(4):761–80 This paper provides a comprehensive outline of genetic factors in the onset of periodontal diseases.CrossRef
5.
Floriano PN, Christodoulides N, Miller CS, Ebersole JL, Spertus J, Rose BG, et al. Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility study. Clin Chem. 2009;55(8):1530–8.CrossRef
6.
Miller CS, Foley JD 3rd, Floriano PN, Christodoulides N, Ebersole JL, Campbell CL, et al. Utility of salivary biomarkers for demonstrating acute myocardial infarction. J Dent Res. 2014;93(7 Suppl):72S–9S.CrossRef
7.
Grassl N, Kulak NA, Pichler G, Geyer PE, Jung J, Schubert S, et al. Ultra-deep and quantitative saliva proteome reveals dynamics of the oral microbiome. Genome Med. 2016;8:44.CrossRef
8.
•• Heikkenen AM, Nwhator SO, Rathnayake N, Mantyla P, Vatanen P, Sorsa T. Pilot study on oral health status as assessed by an active matrix metalloproteinase-8 chairside mouthrinse test in adolescents. J Periodontol. 2016;87(1):36–40 This paper provides data emphasising the role of MMP-8 as a chair-side diagnostic test for periodontal diseases. CrossRef
9.
Miller CS, King CP Jr, Langub MC, Kryscio RJ, Thomas MV. Salivary biomarkers of existing periodontal disease: a cross-sectional study. J Am Dent Assoc. 2006;137(3):322–9.CrossRef
10.
Ramseier CA, Kinney JS, Herr AE, Braun T, Sugai JV, Shelburne CA, et al. Identification of pathogen and host-response markers correlated with periodontal disease. J Periodontol. 2009;80(3):436–46.CrossRef
11.
Costa PP, Trevisan GL, Macedo GO, Palioto DB, Souza SL, Grisi MF, et al. Salivary interleukin-6, matrix metalloproteinase-8, and osteoprotegerin in patients with periodontitis and diabetes. J Periodontol. 2010;81(3):384–91.CrossRef
12.
Gursoy UK, Könönen E, Pradhan-Palikhe P, Tervahartiala T, Pussinen PJ, Suominen-Taipale L, et al. Salivary MMP-8, TIMP-1, and ICTP as markers of advanced periodontitis. J Clin Periodontol. 2010;37(6):487–93.CrossRef
13.
• Kinney JS, Morelli T, Braun T, Ramseier CA, Herr AE, Sugai JV, et al. Saliva/pathogen biomarker signatures and periodontal disease progression. J Dent Res. 2011;90(6):752–8 This paper provides important data on the potential of a group of biomarkers for periodontal disease progression.CrossRef
14.
Zhang L, Li X, Yan H, Huang L. Salivary matrix metalloproteinase (MMP-8) as a biomarker for periodontitis. A PRISMA-compliant systematic review and meta-analysis. Medicine. 2018;97(3):e9642.CrossRef
15.
Sexton WM, Lin Y, Kryscio RJ, Dawson DR 3rd, Ebersole JL, Miller CS. Salivary biomarkers of periodontal disease in response to treatment. J Clin Periodontol. 2011;38(5):434–41.CrossRef
16.
Buduneli N, Bıyıkoğlu B, Sherrabeh S, Lappin DF. Saliva concentrations of RANKL and osteoprotegerin in smoker versus non-smoker chronic periodontitis patients. J Clin Periodontol. 2008;35(10):846–52.CrossRef
17.
Gursoy UK, Könönen E, Pussinen PJ, Tervahartiala T, Hyvärinen K, Suominen AL, et al. Use of host- and bacteria-derived salivary markers in detection of periodontitis: a cumulative approach. Dis Markers. 2011;30(6):299–305.CrossRef
18.
Jaedicke KM, Preshaw PM, Taylor JJ. Salivary cytokines as biomarkers of periodontal diseases. Periodontol 2000. 2016;70(1):164–83.CrossRef
19.
Baltacıoğlu E, Yuva P, Aydın G, Alver A, Kahraman C, Karabulut E, et al. Lipid peroxidation levels and total oxidant/antioxidant status in serum and saliva from patients with chronic and aggressive periodontitis. Oxidative stress index: a new biomarker for periodontal disease? J Periodontol. 2014;85(10):1432–41.CrossRef
20.
Baňasová L, Kamodyová N, Janšáková K, Tóthová Ľ, Stanko P, Turňa J, et al. Salivary DNA and markers of oxidative stress in patients with chronic periodontitis. Clin Oral Investig. 2015;19(2):201–7.CrossRef
21.
Villa-Correa YA, Isaza-Guzmán DM, Tobón-Arroyave SI. Prognostic value of 8-hydroxy-2′-deoxyguanosine and human neutrophil elastase/α1-proteinase inhibitor complex as salivary biomarkers of oxidative stress in chronic periodontitis. J Periodontol. 2015;86(11):1260–7.CrossRef
22.
Novakovic N, Todorovic T, Rakic M, Milinkovic I, Dozic I, Jankovic S, et al. Salivary antioxidants as periodontal biomarkers in evaluation of tissue status and treatment outcome. J Periodontal Res. 2014;49(1):129–36.CrossRef
23.
Bertl K, Schoiber A, Haririan H, Laky M, Steiner I, Rausch WD, et al. Non-surgical periodontal therapy influences salivary melatonin levels. Clin Oral Investig. 2013;17(4):1219–25.CrossRef
24.
Paraskevas S, Huizinga JD, Loos BG. A systematic review and meta-analysis on C-reactive protein in relation to periodontitis. J Clin Periodontol. 2008;35(4):277–90.CrossRef
25.
Vidal F, Figueredo CM, Cordovil I, Fischer RG. Periodontal therapy reduces plasma levels of interleukin-6, C-reactive protein, and fibrinogen in patients with severe periodontitis and refractory arterial hypertension. J Periodontol. 2009;80(5):786–91.CrossRef
26.
de Oliveira C, Watt R, Hamer M. Toothbrushing, inflammation, and risk of cardiovascular disease: results from Scottish health survey. BMJ. 2010;27(340):c2451.CrossRef
27.
Yoshii S, Tsuboi S, Morita I, Takami Y, Adachi K, Inukai J, et al. Temporal association of elevated C-reactive protein and periodontal disease in men. J Periodontol. 2009;80(5):734–9.CrossRef
28.
Buhlin K, Hultin M, Noderyd O, Persson L, Pockley AG, Rabe P, et al. Risk factors for atherosclerosis in cases with severe periodontitis. J Clin Periodontol. 2009;36(7):541–9.CrossRef
29.
Demmer RT, Trinquart L, Zuk A, Fu BC, Blomkvist J, Michalowicz BS, et al. The influence of anti-infective periodontal treatment on C-reactive protein: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2013;8(10):e77441.CrossRef
30.
• Garlanda C, Maina V, Cotena A, Moalli F. The soluble pattern recognition receptor pentraxin-3 in innate immunity, inflammation and fertility. J Reprod Immunol. 2009;83:128–33 This is a pioneering study on the functions of PTX-3. CrossRef
31.
Gümüş P, Nizam N, Nalbantsoy A, Özçaka Ö, Buduneli N. Saliva and serum levels of pentraxin-3 and interleukin-1beta in generalized aggressive or chronic periodontitis. J Periodontol. 2014;85(3):e40–6.CrossRef
32.
Akram Z, Rahim ZH, Taiyeb-Ali TB, Shahdan MS, Baharuddin NA, Vaithilingam RD, et al. Resistin as potential biomarker for chronic periodontitis: a systematic review and meta-analysis. Arch Oral Biol. 2017;73:311–20.CrossRef
33.
Li S, Schmalz G, Schmidt J, Krause F, Haak R, Ziebolz D. Antimicrobial peptides as a possible interlink between periodontal diseases and its risk factors: a systematic review. J Periodontal Res. 2018;53(2):145–55.CrossRef
34.
Hasuike A, Iguchi S, Suziki D, Kawano E, Sato S. Systematic review and assessment of systematic reviews examining the effect of periodontal treatment on glycemic control in patients with diabetes. Med Oral Patol Oral Cir Bucal. 2017;22(2):e167–76.PubMedPubMedCentral
35.
Kardeşler L, Buduneli N, Çetinkalp Ş, Kinane DF. Adipokines and inflammatory mediators after initial periodontal treatment in patients with type 2 diabetes and chronic periodontitis. J Periodontol. 2010;81(1):24–33.CrossRef
36.
Akram Z, Safii SH, Vaithilingam RD, Baharuddin NA, Javed F, Vohra F. Efficacy of non-surgical periodontal therapy in the management of chronic periodontitis among obese and non-obese patients: a systematic review and meta-analysis. Clin Oral Investig. 2016;20(5):903–14.CrossRef
37.
Buduneli N, Bıyıkoğlu B, İlgenli T, Buduneli E, Nalbantsoy A, Saraç F, et al. Is obesity a possible modifier of periodontal disease as a chronic inflammatory process? A case-control study. J Periodontal Res. 2014;49(4):465–71.CrossRef
38.
Bıyıkoğlu B, Buduneli N, Aksu K, Nalbantsoy A, Lappin DF, Evrenosoğlu E, et al. Periodontal therapy in chronic periodontitis lowers gingival crevicular fluid interleukin-1beta and DAS28 in rheumatoid arthritis patients. Rheumatol Int. 2013;33(10):2607–16.CrossRef
39.
Sivestre FJ, Silvestre-Rangil J, Bagan L, Bagan JV. Effect of nonsurgical periodontal treatment in patients with periodontitis and rheumatoid arthritis: a systematic review. Med Oral Patol Oral Cir Bucal. 2016;21(3):e349–54.CrossRef
40.
Özçaka Ö, Ceyhan BÖ, Akcali A, Biçakci N, Lappin DF, Buduneli N. Is there an interaction between polycistic ovary syndrome and gingival inflammation? J Periodontol. 2012;83(12):1529–37.CrossRef
41.
Akcalı A, Bostanci N, Özçaka Ö, Gümüş P, Öztürk-Ceyhan B, Tervahartiala T, et al. Gingival inflammation and salivary or serum granulocyte-secreted enzymes in patients with polycystic ovary syndrome. J Periodontol. 2017;88(11):1145–52.CrossRef
42.
Gümüş P, Kahraman-Çeneli S, Akcalı A, Sorsa T, Tervahartiala T, Buduneli N, et al. Association of thalassemia major and gingival inflammation: a pilot study. Arch Oral Biol. 2016;64:80–4.CrossRef
43.
Akcalı A, Kahraman-Çeneli S, Gümüş P, Buduneli N, Lappin DF, Özçaka Ö. The association between thalassemia major and periodontal health. J Periodontol. 2015;86(9):1047–57.CrossRef
44.
Akcalı A, Gümüş P, Özçaka Ö, Öztürk-Ceyhan B, Tervahartiala T, Husu H, et al. Proteolytic mediators in gestational diabetes mellitus and gingivitis. J Periodontol. 2017;88(3):289–97.CrossRef
45.
Gümüş P, Özçaka Ö, Ceyhan-Öztürk B, Akcalı A, Lappin DF, Buduneli N. Evaluation of biochemical parameters and local and systemic levels of osteoactive and B-cell stimulatory factors in gestational diabetes in the presence or absence of gingivitis. J Periodontol. 2015;86(3):387–97.CrossRef
46.
Papapanou PN, Sanz M, Buduneli N, Dietrich T, Feres M, Fine DH, et al. Periodontitis: consensus report of workgroup 2 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions. J Clin Periodontol. 2018;45(Suppl 20):S162–70.CrossRef
47.
Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: framework and proposal of a new classification and case definition. J Clin Periodontol. 2018;45(Suppl 20):S149–61.CrossRef
Metadata
Title
Biomarkers in Saliva and Serum Samples for Periodontal Disease and Interactions with Systemic Health
Author
Nurcan Buduneli
Publication date
01-03-2019
Publisher
Springer International Publishing
Published in
Current Oral Health Reports / Issue 1/2019
Electronic ISSN: 2196-3002
DOI
https://doi.org/10.1007/s40496-019-0207-5

Other articles of this Issue 1/2019

Current Oral Health Reports 1/2019 Go to the issue

Systemic Diseases (N Buduneli, Section Editor)

Oral Leukoplakia: Present Views on Diagnosis, Management, Communication with Patients, and Research

Systemic Diseases (N Buduneli, Section Editor)

Autoimmunity and the Oral Cavity

Systemic Diseases (N Buduneli, Section Editor)

Is Human Papilloma Virus Infection Linked to Periodontitis? A Narrative Review

Systemic Diseases (N Buduneli, Section Editor)

Medications for Chronic Conditions and Periodontal Disease

Systemic Diseases (N Buduneli, Section Editor)

Association Between Periodontal Diseases and Adverse Gestation Outcomes: a Review of the Current Literature

Correction

Correction to: Association Between Periodontal Diseases and Adverse Gestation Outcomes: a Review of the Current Literature